Daily non-political popular news in brief.

Advances in drug screening: building a better haystack for the needles of tomorrow

With the discovery of suitable molecular targets -- cellular molecules along pathways crucial for sustaining the life of cancer cells -- comes the perplexing dilemma of where to find the next therapeutics that will bind to and disable those targets. While the possibilities for drug designs are near-limitless, the methods to screen drug databases and repositories are often problematic or ill-suited for the particular needs of researchers.

Read more »

Keywords: advances, drug, screening, building, haystack, needles, tomorrow, advance, needle

« Previous | Next »

Similar news on "Advances in drug screening: building a better haystack for the needles of tomorrow":

1. Ireland Cancer Center researchers advance lung cancer treatment
   04-23-2007 · EurekAlert!
   Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
   Similar news · Read more »
   
2. Experimental cancer pharmaceuticals under trial
   10-23-2007 · EurekAlert!
   Advances in drug development have enabled scientists to attack new and unconventional cancer targets, leading to better treatments for cancer patients with fewer unwanted side effects. The following items highlight the early results from two experimental therapeutics, currently involved in Phase I or II trials, which are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
   Similar news · Read more »
   
3. 'Micro' livers could aid drug screening
   11-19-2007 · Massachusetts Institute of Technology (MIT)
   MIT researchers have devised a novel way to create tiny colonies of living human liver cells that model the full-sized organ. The work could reduce costs and allow better screening of new drugs that are potentially harmful to the liver.
   Similar news · Read more »
   
4. Fresh use of targeted therapy advances treatment of early HER2-positive breast cancer
   11-16-2006 · EurekAlert!
   The news that the world's first targeted therapy, trastuzumab (Herceptin), is now available for many women with early-stage HER2-positive breast cancer "highlights a truly significant advance in the management of breast cancer," says Edith Perez, M.D., director of Mayo Clinic's Breast Clinic in Jacksonville, Florida.
   Similar news · Read more »
   
5. Using Life's Building Blocks to Control Nanoparticle Assembly
   08-22-2007 · Brookhaven National Laboratory
   Using DNA, researchers at Brookhaven are studying how to control both the speed of nanoparticle assembly and the structure of resulting nanoclusters. Learning how to control the assembly of nanoparticles could lead to applications from more efficient energy generation to cell-targeted systems for drug delivery.
   Similar news · Read more »
   
6. Annals of Internal Medicine tip sheet for April 3, 2007
   04-02-2007 · EurekAlert!
   The following articles are featured in the upcoming Annals of Internal Medicine: New ACP Guideline for Mammography Screening Encourages Women 40 to 49 Years of Age to Become Part of the Decision-Making Process; Long-Term Effects of False-Positive Mammograms not Clear; New Injected Drug Added to Traditional Drug May Help Type 2 Diabetes; and Study Finds Kidney Dialysis Outcomes Vary by Race and Region.
   Similar news · Read more »
   
7. Drugs users are increasingly more cautious with needles
   05-14-2007 · EurekAlert!
   Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.
   Similar news · Read more »
   
8. Building stronger bones, 1 stem cell at a time
   01-24-2008 · EurekAlert!
   Mesenchymal stem cells are capable of giving rise to various cell types through a process known as differentiation. A new study has determined that the anti-tumor drug bortezomib targets MSCs and leads to bone cell-specific differentiation. These data led the authors to suggest that Bzb might be a novel therapy for bone loss in individuals with osteoporosis and those with cancers accompanied by severe bone disease, such as myeloma.
   Similar news · Read more »
   
9. Penn researchers develop new method for screening drug-resistant forms of HIV
   06-28-2007 · EurekAlert!
   Existing methods of detecting drug-resistant forms of HIV are expensive, time consuming and often fail to identify small populations of drug-resistant HIV. Now, researchers have developed a drug resistance screening method that analyzes multiple HIV variants at the same time, while also saving time and money.
   Similar news · Read more »
   
10. Tip sheet, Annals of Internal Medicine, Dec. 18, 2007, issue
    12-17-2007 · EurekAlert!
    The following articles are in the upcoming issue of Annals of Internal Medicine: "Task Force Does Not Recommend Screening for Carotid Artery Stenosis"; "Vitamin D is Standard Treatment for CKD Despite Evidence"; "Organ Donation Laws Need Revising so that Doctors Give Priority to Care for the Donor Rather than The Organ"; "Study Finds Insufficient Evidence to Decide the Most Effective Treatment to Prevent Osteoporotic Fractures"; and "Balancing Efficacy and Safety of Drug-Eluting Stents."
    Similar news · Read more »